Engineered muscle tissues with enhanced maturation enable the identification of clinically relevant rAAV products
Molecular Therapy Advances
· Elsevier
Аннотация
Publication date: 10 September 2026 Source: Molecular Therapy Advances, Volume 34, Issue 3 Author(s): Clémence Lièvre, Bérangère Robert, Giada Mainieri, Nicolas Jaulin, Marine Cotinat, Ninon Carlet, Tiphaine Girard, Christian Mandrycky, David L. Mack, Oumeya Adjali, Caroline Le Guiner, Bodvaël Fraysse, Jean-Baptiste Dupont
Читать у издателя →
Цитирование
Engineered muscle tissues with enhanced maturation enable the identification of clinically relevant rAAV products. // Molecular Therapy Advances. – URL: https://www.sciencedirect.com/science/article/pii/S3117387X26001692?dgcid=rss_sd_all
Engineered muscle tissues with enhanced maturation enable the identification of clinically relevant rAAV products. Molecular Therapy Advances. https://www.sciencedirect.com/science/article/pii/S3117387X26001692?dgcid=rss_sd_all
“Engineered muscle tissues with enhanced maturation enable the identification of clinically relevant rAAV products.” Molecular Therapy Advances.
@article{article108289,
title = {Engineered muscle tissues with enhanced maturation enable the identification of clinically relevant rAAV products},
journal = {Molecular Therapy Advances},
url = {https://www.sciencedirect.com/science/article/pii/S3117387X26001692?dgcid=rss_sd_all}
}